WebDisclosure WebDisclosure
Basculer en Français
10036 Companies
204447 Keywords
134796 Articles
108447 Press releases
Headlines Articles Press releases SkylineDx Remove
  1. Home
  2. Companies
  3. SkylineDx
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/22/2025 at 17:40, 4 months 25 days ago

    SkylineDx's MERLIN_001 Trial Validates Melanoma Risk Test's Predictive Power

    Melanoma MERLIN_001 Trial Gene Expression Profiling Sentinel Node Metastasis SkylineDx
  • BRIEF

    published on 10/22/2025 at 17:40, 4 months 25 days ago

    L'essai MERLIN_001 de SkylineDx valide le pouvoir prédictif du test de risque de mélanome

    Mélanome SkylineDx Essai MERLIN_001 Profilage De L'expression Génétique Métastase Du Ganglion Sentinelle
  • PRESS RELEASE

    published on 10/22/2025 at 17:35, 4 months 25 days ago

    SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma

    SkylineDx publishes results from the landmark MERLIN_001 trial in JAMA Surgery validating the predictive power of the Merlin CP-GEP Test for melanoma patients
    Melanoma MERLIN_001 Trial SkylineDx JAMA Surgery CP-GEP Test
    Logo of SkylineDx
Accesswire
  • Published on 03/16/2026 at 21:00, 29 minutes ago

    Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA

  • Published on 03/16/2026 at 19:55, 1 hour 34 minutes ago

    GGL Resources Corp. Updates the Status of its Earn-In Agreement on its Gold Point High-Grade Gold-Silver Project, Nevada

  • Published on 03/16/2026 at 18:12, 3 hours 17 minutes ago

    Sekur Private Data Signs Distribution Agreement In Africa

  • Published on 03/16/2026 at 14:00, 7 hours 29 minutes ago

    Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression

  • Published on 03/16/2026 at 13:45, 7 hours 44 minutes ago

    iFabric Corp Provides Strong 2025 Revenue Estimate and 2026 Outlook

View all ACCESSWIRE
EQS Group
  • Published on 03/16/2026 at 20:53, 35 minutes ago

    EQS-Adhoc: EPH Group AG: Extension of Alexander Lühr’s Executive Board contract; appointment of an additional Executive Board member

  • Published on 03/16/2026 at 19:50, 1 hour 39 minutes ago

    EQS-Adhoc: Softing AG approves 10% cash capital increase excluding subscription rights

  • Published on 03/16/2026 at 19:45, 1 hour 44 minutes ago

    EQS-Adhoc: Northern Data Announces FY 2025 preliminary Financial Results

  • Published on 03/16/2026 at 19:24, 2 hours 4 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 03/16/2026 at 19:00, 2 hours 29 minutes ago

    PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 09 MARS 2026 au 13 MARS 2026

View all EQS
Les Echos
  • Published on 03/16/2026 at 18:00, 3 hours 29 minutes ago

    Disclosure of trading in own shares from 09/03/2026 to 13/03/2026

  • Published on 03/16/2026 at 18:00, 3 hours 29 minutes ago

    Déclaration des transactions sur actions propres réalisées du 09/03/2026 au 13/03/2026

  • Published on 03/16/2026 at 17:58, 3 hours 31 minutes ago

    Aéroports de Paris S.A - February 2026 traffic figures

  • Published on 03/16/2026 at 17:58, 3 hours 31 minutes ago

    Aéroports de Paris S.A - Trafic du mois de février 2026

  • Published on 03/16/2026 at 17:56, 3 hours 32 minutes ago

    Reporting on share buyback transactions carried out between March 9 and March 13, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy